Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease.

Michael F MorrisYash PershadPaul KangLauren RidenourBen LavonMaarten LanclusRik GodonJan De BackerMarilyn K Glassberg

Published in: The European respiratory journal (2021)

The data suggest BV5% as a novel biomarker for predicting adverse outcomes in patients with COVID-19 seeking acute medical care.

Keyphrases